Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKesson
Cerilliant
Fish and Richardson
US Army
Fuji
UBS
McKinsey
Express Scripts

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072025

« Back to Dashboard

NDA 072025 describes METAPROTERENOL SULFATE, which is a drug marketed by Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, G And W Labs Inc, Morton Grove, Silarx, Am Therap, Par Pharm, Teva, Usl Pharma, and Watson Labs, and is included in twenty-nine NDAs. It is available from two suppliers. Additional details are available on the METAPROTERENOL SULFATE profile page.

The generic ingredient in METAPROTERENOL SULFATE is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.
Summary for 072025
Tradename:METAPROTERENOL SULFATE
Applicant:Par Pharm
Ingredient:metaproterenol sulfate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072025
Mechanism of ActionAdrenergic beta2-Agonists
Suppliers and Packaging for NDA: 072025
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 072025 ANDA Par Pharmaceutical, Inc. 49884-259 49884-259-01 100 TABLET in 1 BOTTLE (49884-259-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jun 28, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
QuintilesIMS
Queensland Health
Chubb
Fuji
McKinsey
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot